PT283 – Greg McKee – Psychedelics for Nociplastic Pain

<p><span style="font-weight: 400;">In this episode of the podcast, Joe interviews Greg McKee: Chairman and CEO of Tryp Therapeutics, an early-stage biotech company researching the use of psilocybin derivatives to alleviate nociplastic pain like fibromyalgia.  </span></p> <p><a href="http://www.psychedelicstoday.com"><span style= "font-weight: 400;">www.psychedelicstoday.com</span></a></p>